| Lung Neoplasms |
NCT01279798: Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L) |
|
|
| No Longer Available | N/A | | US | Lucanix® (belagenpumatucel-L), Lucanix | NovaRx Corporation | Non-small Cell Lung Cancer | | | | |
NCT02066883: Prognostic Potential Cell Surface Markers CD47 / CD27 / CD8 and Pim-kinase in Patients With Hematologic Malignancies or Solid Tumors |
|
|
| Recruiting | N/A | 150 | RoW | | Cancer Centre of Monoclonal Therapy, LLC | Solid Tumor, Ovarian Cancer, Non-small Cell Lung Cancer, Chronic Lymphocytic Leukemia, Burkitt's Lymphoma | 07/15 | 02/17 | | |
NCT02271139: Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy |
|
|
| No Longer Available | N/A | | US | Alectinib | Genentech, Inc. | Non-Small Cell Lung Cancer | | | | |
NCT01896804: Calcitriol in Preventing Lung Cancer in High-Risk Patients |
|
|
| Recruiting | N/A | 40 | US | Calcitriol, 1,25(OH)2-D3, 1,25-Dihydroxycholecalciferol, Calcijex, Rocaltrol, Laboratory Biomarker Analysis, Pharmacological Study | Roswell Park Cancer Institute, National Cancer Institute (NCI) | Angiogenic Squamous Dysplasia, Bronchial Intraepithelial Neoplasia, Squamous Metaplasia | 12/17 | | | |
NCT01317953: Oral Green Tea Extract for Small Cell Lung Cancer |
|
|
| Available | N/A | | RoW | epigallocatechin gallate, EGCG | Shandong Cancer Hospital and Institute | Small Cell Lung Carcinoma | | | | |
| Recruiting | N/A | 1000 | US | Registry, PDT | Main Line Health, Pinnacle Biologics Inc. | Lung Cancer, Esophageal | 11/24 | 12/24 | | |
NCT01595074: Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 950 | Canada | medical chart review, chart review, laboratory biomarker analysis | National Cancer Institute (NCI) | Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer | 01/00 | | | |
